The 'Bone-Brain' Crosstalk Mechanism of Subchondral Bone Nociceptive Sensitization Activating SPP1-Positive Microglia in the vlPAG Region Elucidates the Theoretical Connotation of Treating Knee Osteoarthritis Based on Kidney Differentiation
1 other identifier
observational
120
0 countries
N/A
Brief Summary
The aim of this observational study is to investigate the relationship between pain severity and alterations in bone-derived and brain-derived signaling molecules (including serum neurotransmitters and inflammatory cytokines), as well as structural and functional changes in the ventrolateral periaqueductal gray (vlPAG) region in patients with kidney-deficiency type knee osteoarthritis (KOA). The central question it seeks to address is whether changes in these signaling molecules and vlPAG alterations are associated with the degree of pain. Patients scheduled to undergo total knee arthroplasty (TKA) due to KOA will be enrolled prior to surgery. Before the operation, they will undergo questionnaire assessments, physical examinations, imaging evaluations, and blood sample collection. The resected tibial plateau tissue obtained during surgery will be used for subsequent laboratory analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedStudy Start
First participant enrolled
June 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
May 18, 2025
April 1, 2025
1.5 years
April 12, 2025
May 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index
The WOMAC Index is a validated instrument used to assess pain, stiffness, and physical dysfunction in patients with osteoarthritis. It comprises 3 subscales with a total of 24 items, yielding a total score ranging from 0 to 96, where higher scores indicate more severe symptoms and greater functional impairment.
Participants were tested immediately after being included in the study.
Secondary Outcomes (16)
Visual Analog Scale (VAS) score
Participants were tested immediately after being included in the study.
Pattern Element Analysis
Participants were tested immediately after being included in the study.
Function of Knee Joint
Participants were tested immediately after being included in the study.
Volume of Subchondral Cystic Lesions
Participants were tested immediately after being included in the study.
Brain Region Structure
Participants were tested immediately after being included in the study.
- +11 more secondary outcomes
Study Arms (2)
KOA
Patients with knee osteoarthritis of renal deficiency type who meet the diagnostic criteria
HC
Healthy volunteers
Eligibility Criteria
Patients with knee osteoarthritis of kidney deficiency type from the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine. And the healthy volunteers recruited by the research team.
You may qualify if:
- Clinical diagnosis of KOA
- Age between 60-70 years.
- Kellgren-Lawrence grade IV on anteroposterior and lateral knee X-rays.
- Scheduled for total knee arthroplasty.
- Voluntarily signs informed consent.
You may not qualify if:
- Clinical diagnosis of ankylosing spondylitis, rheumatoid arthritis, gout, or other related conditions.
- Presence of metabolic bone diseases, acute trauma, malignancies, infections, or other complications severely affecting knee function.
- Use of drugs affecting bone metabolism (e.g., corticosteroids, zoledronic acid) within the past 6 months.
- Presence of psychiatric disorders or serious cardiovascular, pulmonary, renal, hepatic, hematologic, or other systemic diseases.
- Contraindications to MRI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jinchao Xulead
Biospecimen
Tibial plateau samples obtained from KOA patients during total knee arthroplasty.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
April 12, 2025
First Posted
May 18, 2025
Study Start
June 15, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
May 18, 2025
Record last verified: 2025-04